SwRI Breaks Ground on Advanced Clinical Supply Facility for Therapeutic Production
SwRI breaks ground on a new facility to boost small-batch therapeutics and clinical trial support.
Southwest Research Institute (SwRI) has started construction on a new 21,000-square-foot Clinical Supply Facility aimed at advancing pharmaceutical research and development. This facility will focus on producing small-batch therapeutics for clinical trials, particularly targeting rare diseases, vaccines, and stem cell therapies. It will also feature state-of-the-art clean room environments and advanced drug discovery platforms.
The new site will enhance SwRI's ability to meet regulatory demands while supporting global clients. The expanded capabilities will help accelerate research, especially in cancer and viral treatments.
SwRI's new facility underscores its commitment to innovation, providing crucial support for the growing field of clinical therapeutics. With a focus on small molecule drugs and highly specialized therapies, the facility will play a vital role in advancing healthcare solutions.
My international experience as a researcher in Taiwan for three years has equipped me with a global perspective, enabling me to create content that resonates with an international audience.
Mehr aus Pharma News
Alle Beiträge →
Curia New York erhält FDA-Warnschreiben wegen Tausender undokumentierter chromatographischer Injektionen
Ab Science überarbeitet Studienzeitpläne nach drei GCP-Inspektionen
Discussion